FDA Warning Letter — MONQ

Case 613570 — FEI 3013968294

The FDA took a Warning Letter action against MONQ on Jun 30, 2022 (Goodlettsville, TN). The action was issued by CDER and concerns drugs products.

Action Details

Facility
MONQ
Date
Jun 30, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Goodlettsville, TN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.